This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2018 Mar 8;378(10):954-959.

doi: 10.1056/NEJMsr1715626.

Balancing Safety and Innovation for Cell-Based Regenerative Medicine

Peter Marks¹, Scott Gottlieb¹

Affiliations

PMID: 29514023
DOI: 10.1056/NEJMsr1715626

Free article

Balancing Safety and Innovation for Cell-Based Regenerative Medicine

Peter Marks et al. N Engl J Med. 2018.

Free article

. 2018 Mar 8;378(10):954-959.

doi: 10.1056/NEJMsr1715626.

Authors

Peter Marks¹, Scott Gottlieb¹

Affiliation

¹ From the Food and Drug Administration, Silver Spring, MD.

PMID: 29514023
DOI: 10.1056/NEJMsr1715626

No abstract available

PubMed Disclaimer

Similar articles

Rejuvenating Regenerative Medicine Regulation.
Charo RA, Sipp D. Charo RA, et al. N Engl J Med. 2018 Feb 8;378(6):504-505. doi: 10.1056/NEJMp1715736. Epub 2018 Jan 10. N Engl J Med. 2018. PMID: 29320637 No abstract available.
The government's role in advancing regenerative medicine and tissue engineering - science, safety, and ethics.
Smith DS. Smith DS. Periodontol 2000. 2006;41:16-29. doi: 10.1111/j.1600-0757.2006.00177.x. Periodontol 2000. 2006. PMID: 16686924 No abstract available.
Informed consent and living human cells.
Maloney DM. Maloney DM. Hum Res Rep. 2002 Jul;17(7):3. Hum Res Rep. 2002. PMID: 12731490 No abstract available.
Regulation of Regenerative Medicine Products.
Gee AP. Gee AP. Adv Exp Med Biol. 2018;1098:189-198. doi: 10.1007/978-3-319-97421-7_10. Adv Exp Med Biol. 2018. PMID: 30238372 Review.
Governmental Regulations and Increasing Food and Drug Administration Oversight of Regenerative Medicine Products: What's New in 2020?
Fang WH, Vangsness CT Jr. Fang WH, et al. Arthroscopy. 2020 Oct;36(10):2765-2770. doi: 10.1016/j.arthro.2020.05.015. Epub 2020 May 20. Arthroscopy. 2020. PMID: 32442713 Review.

See all similar articles

Cited by

Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions.
Ogbogu U, Case N. Ogbogu U, et al. F1000Res. 2024 Aug 27;12:1165. doi: 10.12688/f1000research.141002.2. eCollection 2023. F1000Res. 2024. PMID: 39430869 Free PMC article.
Macrophage microRNA-146a is a central regulator of the foreign body response to biomaterial implants.
Mahanty M, Dutta B, Ou W, Zhu X, Bromberg JS, He X, Rahaman SO. Mahanty M, et al. Biomaterials. 2025 Mar;314:122855. doi: 10.1016/j.biomaterials.2024.122855. Epub 2024 Sep 29. Biomaterials. 2025. PMID: 39362025
Optimization strategies for mesenchymal stem cell-based analgesia therapy: a promising therapy for pain management.
Zhang J, Wu P, Wen Q. Zhang J, et al. Stem Cell Res Ther. 2024 Jul 18;15(1):211. doi: 10.1186/s13287-024-03828-8. Stem Cell Res Ther. 2024. PMID: 39020426 Free PMC article. Review.
Translation of cell therapies to treat autoimmune disorders.
Mehta JM, Hiremath SC, Chilimba C, Ghasemi A, Weaver JD. Mehta JM, et al. Adv Drug Deliv Rev. 2024 Feb;205:115161. doi: 10.1016/j.addr.2023.115161. Epub 2023 Dec 22. Adv Drug Deliv Rev. 2024. PMID: 38142739 Review.
Expanding access to CAR T cell therapies through local manufacturing.
Elsallab M, Maus MV. Elsallab M, et al. Nat Biotechnol. 2023 Dec;41(12):1698-1708. doi: 10.1038/s41587-023-01981-8. Epub 2023 Oct 26. Nat Biotechnol. 2023. PMID: 37884746 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations